Please login to the form below

Not currently logged in
Email:
Password:

early access

This page shows the latest early access news and features for those working in and with pharma, biotech and healthcare.

Krystal Bio preps pivotal trials for rare skin disease gene therapy

Krystal Bio preps pivotal trials for rare skin disease gene therapy

CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.

Latest news

More from news
Approximately 72 fully matching, plus 148 partially matching documents found.

Latest Intelligence

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    For this new environment, we need people who understand a patient pathway and how to access it. ... Instead of being highly trained sales people, they need to be highly efficient facilitators, helping HCPs to get patients early access to the right

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    increased. patient access. “They need to recognise that this is the opportunity of the century and they should seize it.”. ... We are looking at a hybrid solution that offers favourable pricing and increased access for the patients.

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Diagnosis of rare disease is challenging; physicians may only see a handful of cases in their career and information surrounding them is often lacking or difficult to access. ... CROs and trial design • Early access and regulation • Value

  • Rare diseases: meeting the challenge Rare diseases: meeting the challenge

    Ambitious strategy. “Companies need to set an ambitious strategy for pricing and market access early on,” Barham continues. ... No system is perfect,” Barham concludes. “But there is scope for improvements in all countries to try to reach a

  • Can UK pharma rise to the post-Brexit challenge? Can UK pharma rise to the post-Brexit challenge?

    Marketing authorisations. With no access to the single market, UK pharmaceutical companies will be forced to make two separate regulatory submissions - one to the EU and one to the UK. ... 4.The Early Access to Medicine Scheme (EAMS) could be adopted

More from intelligence
Approximately 5 fully matching, plus 35 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • TVF Communications shortlisted for the second year in a row for Writing Excellence award at Communique 2017

    A primary aim was to overcome the challenges associated with lack of early diagnosis, patient access, availability of treatment and patient stigma, which in partnership with AbbVie was made possible.

  • How can pharma help the NHS drive much-needed change in mental health services?

    The PoE programme aims to achieve this through prevention, early intervention, access to crisis care on a 24/7 basis and better integration of mental and physical healthcare.  . ... Changes that could help to achieve PoE   . Early intervention is key

  • Accession

    The early industry pioneers of market access, are the creative force behind Accession. ... Today we are a specialist team of market access innovators, go-getters, strategists, scientists, analysts, and economists.

  • Determining value to withstand all tests

    The article in Pharmaceutical Marketing Europe discusses the need for functions to better join forces early in the access continuum in the interest of defining and delivering value that is going

  • Oncology drugs under AMNOG

    Part 1: Segmentation and comparator choice - lessons for cancer drug market access in Germany. ... The AMNOG early benefit assessment process in Germany is now over three years old and as tweaks are made to regulations and manufacturers gain more

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics